Imricor Medical Systems Inc (IMR) - Net Assets

Latest as of December 2025: AU$11.53 Million AUD ≈ $8.16 Million USD

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has net assets worth AU$11.53 Million AUD (≈ $8.16 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$45.79 Million ≈ $32.40 Million USD) and total liabilities (AU$34.26 Million ≈ $24.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IMR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$11.53 Million
% of Total Assets 25.18%
Annual Growth Rate N/A
5-Year Change -48.52%
10-Year Change N/A
Growth Volatility 172.99

Imricor Medical Systems Inc - Net Assets Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. See IMR days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual net assets of Imricor Medical Systems Inc from 2016 to 2025. For live valuation and market cap data, see IMR stock market capitalisation.

Year Net Assets Change
2025-12-31 AU$11.53 Million
≈ $8.16 Million		 +256.31%
2024-12-31 AU$-7.38 Million
≈ $-5.22 Million		 +15.72%
2023-12-31 AU$-8.75 Million
≈ $-6.19 Million		 -216.55%
2022-12-31 AU$7.51 Million
≈ $5.31 Million		 -66.47%
2021-12-31 AU$22.40 Million
≈ $15.85 Million		 -22.26%
2020-12-31 AU$28.82 Million
≈ $20.39 Million		 +309.70%
2019-12-31 AU$7.03 Million
≈ $4.98 Million		 -47.78%
2018-12-31 AU$13.47 Million
≈ $9.53 Million		 +356.44%
2017-12-31 AU$-5.25 Million
≈ $-3.72 Million		 -30.31%
2016-12-31 AU$-4.03 Million
≈ $-2.85 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Imricor Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 14043102900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock AU$32.12K 0.28%
Other Components AU$179.21 Million 1554.15%
Total Equity AU$11.53 Million 100.00%

Imricor Medical Systems Inc Competitors by Market Cap

The table below lists competitors of Imricor Medical Systems Inc ranked by their market capitalization.

Company Market Cap
USI Corp
TW:1304
 $457.76 Million
PCL Technologies Inc
TW:4977
 $457.84 Million
Vastned Retail Belgium
BR:VASTB
 $457.90 Million
Beihai Gofar Marine Biological Industry Co Ltd
SHG:600538
 $457.94 Million
Calfrac Well Services Ltd.
TO:CFW
 $457.48 Million
PowerFleet, Inc.
NASDAQ:AIOT
 $457.44 Million
Nuveen Multi-Asset Income Fund
NYSE:NMAI
 $457.26 Million
Thaitheparos Public Company Limited
BK:SAUCE
 $457.25 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Imricor Medical Systems Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -7,377,033 to 11,531,084, a change of 18,908,117.
  • Net loss of 26,201,489 reduced equity.
  • Share repurchases of 1,358,818 reduced equity.
  • New share issuances of 44,568,544 increased equity.
  • Other factors increased equity by 1,899,880.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-26.20 Million -227.22%
Share Repurchases AU$1.36 Million -11.78%
Share Issuances AU$44.57 Million +386.51%
Other Changes AU$1.90 Million +16.48%
Total Change AU$- %

Book Value vs Market Value Analysis

This analysis compares Imricor Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 49.00x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 AU$-0.04 AU$1.83 x
2017-12-31 AU$-0.05 AU$1.83 x
2018-12-31 AU$0.14 AU$1.83 x
2019-12-31 AU$0.07 AU$1.83 x
2020-12-31 AU$0.25 AU$1.83 x
2021-12-31 AU$0.17 AU$1.83 x
2022-12-31 AU$0.05 AU$1.83 x
2023-12-31 AU$-0.08 AU$1.83 x
2024-12-31 AU$-0.03 AU$1.83 x
2025-12-31 AU$0.04 AU$1.83 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Imricor Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -227.22%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -8661.59%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 3.97x
  • Recent ROE (-227.22%) is below the historical average (-86.24%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% -780.61% 0.20x 0.00x AU$-5.09 Million
2017 0.00% -1186.48% 0.19x 0.00x AU$-6.19 Million
2018 -54.18% -543.52% 0.08x 1.19x AU$-8.64 Million
2019 -210.40% -2313.28% 0.06x 1.50x AU$-15.50 Million
2020 -45.38% -1862.37% 0.02x 1.16x AU$-15.96 Million
2021 -91.77% -2952.33% 0.03x 1.20x AU$-22.80 Million
2022 -233.46% -2148.77% 0.06x 1.82x AU$-18.29 Million
2023 0.00% -3675.61% 0.07x 0.00x AU$-21.34 Million
2024 0.00% -3094.86% 0.04x 0.00x AU$-28.96 Million
2025 -227.22% -8661.59% 0.01x 3.97x AU$-27.35 Million

Industry Comparison

This section compares Imricor Medical Systems Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $194,539,512
  • Average return on equity (ROE) among peers: -192.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Imricor Medical Systems Inc (IMR) AU$11.53 Million 0.00% 2.97x $457.57 Million
4DMEDICAL Ltd (4DX) $926.64K -85.93% 0.18x $1.84 Billion
Adherium Ltd (ADR) $830.00K -1420.96% 1.70x $7.60 Million
Aroa Biosurgery Ltd (ARX) $53.69 Million -32.84% 0.36x $154.57 Million
Atomo Diagnostics Ltd (AT1) $6.98 Million -71.26% 0.33x $12.75 Million
Avita Medical Inc (AVH) $16.23 Million 0.00% 0.05x $119.77 Million
Anteris Technologies Global Corp (AVR) $5.01 Million 0.00% 0.01x $848.00 Million
Control Bionics Ltd (CBL) $6.27 Million -94.35% 0.44x $26.53 Million
Cardiex Ltd (CDX) $3.28 Million -81.11% 0.41x $13.23 Million
Compumedics Ltd (CMP) $11.68 Million -158.94% 1.04x $35.62 Million
Cochlear Ltd (COH) $1.84 Billion 19.39% 0.49x $5.47 Billion

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$457.57 Million
AU$646.68 Million AUD
Market Cap Rank
#12870 Global
#337 in Australia
Share Price
AU$1.83
Change (1 day)
-2.14%
52-Week Range
AU$1.20 - AU$2.20
All Time High
AU$2.79
Categories
Companies in Australia Medical Devices
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more